ALBUTEROL SULFATE

PRODUCT IDENTIFICATION

CAS NO. 18559-94-9 35763-26-9 (base)
51022-70-9, 36519-31-0 (sulfate)

ALBUTEROL 

EINECS NO. 242-424-0
256-916-8
FORMULA C26H42N2O6 · H2SO4
MOL WT. 288.35

H.S. CODE

2922.50.1300

TOXICITY

Oral Rat LD50: > 2500mg/kg
SYNONYMS (±)-Salbutamol sulfate; Venetlin; DL-Albuterol sulfate;
1-(4-Hydroxy-3-hydroxymethylphenyl)-2-(tert-butylamino)ethanol sulfate; Bis((tert-butyl)(beta,3,4-trihydroxyphenethyl)ammonium) sulphate; alpha(1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol sulfate; DL-N-tert-Butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine; DL-Salbutamol sulfate; alpha-((tert-Butylamino)methyl)-4-hydroxy-1,3-benzenedimethanol sulfate; 2-tert-Butylamino-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol hemisulfate;
SMILES S(O)(=O)(=O)O.c1(cc([C@@H](CNC(C)(C)C)O)ccc1O)CO. c1(c(ccc(c1)[C@@H](CNC(C)(C)C)O)O)CO

CLASSIFICATION

Adrenergic agent, Adrenergic agonist, Adrenergic beta-agonist, Anti-Asthmatic agent, Autonomic agent, Bronchodilator, Neurotransmitter Agent, Tocolytic agent

EXTRA NOTES

A racemic mixture with a 1:1 ratio of the r-isomer, levalbuterol, and s-albuterol. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.  It is a short-acting beta2-adrenergic agonist with its main clinical use in ASTHMA.

PHYSICAL AND CHEMICAL PROPERTIES

PHYSICAL STATE white to off-white crystalline powder
MELTING POINT 240 C
BOILING POINT

 

SPECIFIC GRAVITY

 

SOLUBILITY IN WATER Soluble
SOLVENT SOLUBILITY Very slightly soluble in ethanol and in methylene chloride
pH  
VAPOR DENSITY

 

AUTOIGNITION

 

NFPA RATINGS

Health hazard: 1, Fire: 0, Reactivity Hazard: 0

REFRACTIVE INDEX

 

FLASH POINT

> 250 C

STABILITY

Stable under ordinary conditions.

EXTERNAL LINKS & GENERAL DESCRIPTION

Wikipedia Linking

http://www.medilexicon.com/
Mechanism of Action:In vitro studies and in vivo pharmacologic studies have demonstrated that albuterol has a preferential effect on beta2-adrenergic receptors compared to isoproterenol. Activation of beta2-adrenergic receptors on airway smooth muscle leads to the activation of adenylcyclase, and to an increase in the intracellular concentration of cyclic-3',5'-adenosine monophosphate (cyclic AMP). This increase of cyclic AMP leads to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation. Albuterol relaxes the smooth muscles of all airways, from the trachea to the terminal bonchioles. Albuterol acts as a functional antagonist to relax the airway irrespective of the spasmogen involved, thus protecting against all bronchoconstrictor challenges. (from Ventolin HFA Product Information)

Google Scholar Search

http://molpharm.aspetjournals.org/
Different Ability of Clenbuterol and Salbutamol to Block Sodium Channels Predicts Their Therapeutic Use in Muscle Excitability Disorders

Drug Information Portal (U.S. National Library of Medicine) - ALBUTEROL

http://www.drugbank.ca/
Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and
COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity. This lead to the development of levalbuterol, the single R-isomer of salbutamol. However, the high cost of levalbuterol compared to salbutamol has deterred wide-spread use of this enantiomerically pure version of the drug. Salbutamol is generally used for acute episodes of bronchospasm caused by bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders such as chronic obstructive pulmonary disorder (COPD). It is also used prophylactically for exercise-induced asthma.

SALES SPECIFICATION

APPEARANCE

white to off-white crystalline powder

IDENTIFICATION

passes Test A,B,C,D

ASSAY

98.0 - 101.0%
CLARITY OF SOL.

BY6 max

LOSS ON DRYING

0.5% max

IMPURITIES

Individual impurity: 0.3% max, Total impurity: 1.0% max

SULPHATED ASH

0.1% max

TRANSPORTATION
PACKING
 
HAZARD CLASS Not regulated
UN NO.  
SAFETY INFORMATION

GHS

 

SIGNAL WORD Warning

PICTOGRAMS

HAZARD STATEMENTS

H302 Harmful if swallowed

PRECAUTIONARY STATEMENTS

P264 Wash hands thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P301+P312 IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P330 Rinse mouth.
P501 Dispose of contents/container to

EC DIRECTIVES

 

HAZARD CODES

XI Irritant

RISK PHRASES

43 May cause sensitization by skin contact

SAFETY PHRASES

36/37 Wear suitable protective clothing and gloves

PRICE INFORMATION